Thymectomy Trial in Non-Thymomatous Myasthenia Gravis Patients Receiving Prednisone Therapy
A Multi-Center, Single-Blind, Randomized Study Comparing Thymectomy to No Thymectomy in Non-Thymomatous Myasthenia Gravis (MG) Patients Receiving Prednisone A Multi-Center, Single-Blind, Randomized Study Comparing Thymectomy to No Thymectomy in Non-Thymomat ...
Myasthenia Gravis
Procedure: thymectomy plus prednisone;Drug: prednisone alone
University of Alabama at Birmingham
National Institute of Neurological Disorders and Stroke (NINDS)
Completed
18 Years
65 Years
All
126
Phase 3
United States;Argentina;Australia;Brazil;Canada;Chile;Germany;Italy;Japan;Mexico;Netherlands;Poland;Portugal;South Africa;Spain;Taiwan;Thailand;United Kingdom;Ireland United States;Argentina;Australia;Brazil;Canada;Chile;Germany;Italy;Japan;Mexico;Netherlands;Poland; ...
Extended Follow-up of Treatment of Prednisone Plus Cyclophosphamide in Patients With Advanced-stage IgA Nephropathy Extended Follow-up of Treatment of Prednisone Plus Cyclophosphamide in Patients With Advanced-stage ...
An Extended Follow-up of the Prospective Randomized, Controlled, Open-labeled Trial of Prednisone Plus Cyclophosphamide in Patients With Advanced Stage IgA Nephropathy An Extended Follow-up of the Prospective Randomized, Controlled, Open-labeled Trial of Prednisone Pl ...
IgA Nephropathy
Drug: prednisone and cyclophosphamide;Drug: prednisone alone
Treatment of Prednisone Plus Cyclophosphamide in Patients With Advanced-stage IgA Nephropathy
A Prospective Randomized, Controlled, Open-labeled Trial of Prednisone Plus Cyclophosphamide in Patients With Advanced-stage IgA Nephropathy A Prospective Randomized, Controlled, Open-labeled Trial of Prednisone Plus Cyclophosphamide in Pati ...
IgA Nephropathy
Drug: prednisone plus cyclophosphamide;Drug: Prednisone alone